rs772881093
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PP3_ModeratePP5
The NM_014249.4(NR2E3):c.305C>A(p.Ala102Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000554 in 1,551,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A102S) has been classified as Uncertain significance.
Frequency
Consequence
NM_014249.4 missense
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 37Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- enhanced S-cone syndromeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Goldmann-Favre syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NR2E3 | ENST00000617575.5 | c.305C>A | p.Ala102Asp | missense_variant | Exon 3 of 8 | 1 | NM_014249.4 | ENSP00000482504.1 | ||
| NR2E3 | ENST00000621098.1 | c.305C>A | p.Ala102Asp | missense_variant | Exon 3 of 7 | 1 | ENSP00000479962.1 | |||
| NR2E3 | ENST00000621736.4 | c.41C>A | p.Ala14Asp | missense_variant | Exon 5 of 10 | 2 | ENSP00000479254.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152174Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000393 AC: 6AN: 152790 AF XY: 0.0000615 show subpopulations
GnomAD4 exome AF: 0.0000579 AC: 81AN: 1399140Hom.: 0 Cov.: 33 AF XY: 0.0000638 AC XY: 44AN XY: 690156 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74332 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Abnormality of the eye Pathogenic:1
Undetermined rare ocular disorder with frequency of less than eight patients -
Enhanced S-cone syndrome Pathogenic:1
- -
Enhanced S-cone syndrome;C1970163:Retinitis pigmentosa 37 Pathogenic:1
- -
Retinitis pigmentosa 37 Pathogenic:1
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with recessive enhanced S-cone syndrome (ESCS; MIM#268100) and both dominant and recessive retinitis pigmentosa 37 (RP37; MIM#611131). Missense variants with a dominant negative mechanism have been rarely reported to cause dominant RP37, whereas loss of function variants cause recessive RP37 or ESCS (ClinVar, PMID: 19006237). (I) 0108 - This gene is associated with both recessive and dominant disease (OMIM). (I) 0115 - Variants in this gene are known to have variable expressivity in individuals with ESCS (PMID: 32679203). (I) 0200 - Variant is predicted to result in a missense amino acid change from alanine to aspartic acid. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (6 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2) (6 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated NR C4-type zinc finger motif (UniProt). (I) 0710 - Another missense variant comparable to the one identified in this case has inconclusive previous evidence for pathogenicity. This alternative change (p.(Ala102Ser)) has been reported as a VUS (ClinVar). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported as likely pathogenic, and observed in multiple compound heterozygous individuals and a single homozygous individual with inherited retinal disease, enhanced S-cone syndrome, retinal dystrophy or retinitis pigmentosa. One of these individuals is also heterozygous for a variant in the FLVCR1 gene, and in another, zygosity was unclear (ClinVar, PMID: 28041643; PMID: 25079116, PMID: 27033713, PMID: 31884612, PMID: 32679203, PMID: 28559085). (SP) 1206 - This variant has been shown to be paternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Retinal dystrophy Pathogenic:1
- -
not provided Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 102 of the NR2E3 protein (p.Ala102Asp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with enhanced S-cone syndrome and/or inherited retinal dystrophy (PMID: 25079116, 26894784, 28559085, 32581362, 32679203). ClinVar contains an entry for this variant (Variation ID: 438227). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NR2E3 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at